National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Treatment Choices for Men With Early-Stage Prostate Cancer
    Posted: 02/14/2006



Introduction






Facts about Prostate Cancer






Thinking About Treatment Choices






Comparing Your Treatment Options






Making a Choice About Treatment






Resources



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Order Free Copy
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Thinking About Treatment Choices

Medical Test and Terms
Tumor Stages
Types of Treatment

Watchful waiting, surgery, and radiation therapy are the standard treatment choices for early-stage prostate cancer (see Types of Treatment). Each has benefits (how treatment can help) and risks (problems treatment may cause). There is seldom just one "right" treatment choice.

"The bottom line is to have enough information to know what treatment to choose." - Ken

Treatment choices depend on several factors:

  • Prostate cancer characteristics. This includes the size of your prostate, prostate-specific antigen (PSA) score, Gleason score, and stage of cancer. (Go to Medical Tests and Terms to learn more.)

  • Health problems, other than prostate cancer. This means whether you have heart problems, diabetes, or other illnesses or have had a previous surgery for an enlarged prostate. Having such health problems may affect which treatment you choose.

  • Age. If you are older, you may view treatment choices differently than younger men because the benefits and risks of treatment vary with age.

  • Type of care available to you. The skills of specialists and types of treatment can vary. You will need to ask what you may feel are tough questions to make sure that you get the best care and outcomes. See Talking with Your Medical Team and Asking Questions for questions to ask.

  • Balancing what you value most.Your unique experiences in life shape your feelings and perceptions about how to deal with your prostate cancer. Keep in mind what is important to you personally to help guide your decision.

    Many men may ask their doctor, "What would you do, if you were me?" Try to remember, the doctor isn't you and his or her personal values may be different from yours.

    How do you view the potential risks and benefits of the treatment options offered to you? Are you a person who could cope with knowing cancer is in your body? Would you rather have the cancer treated and know that there could be side effects? Do you know of other men's experiences with prostate cancer that may influence your decision?

  • Spouse or partner. Even though the treatment decision is yours, involve your spouse, partner, or caregiver to help you sort out what is most important to you and your family. Your treatment choice will affect your spouse or partner.

Medical Test and Terms

By now you may have had several tests to find out the extent of your cancer. Your doctor will take into account your physical exam, PSA level, Gleason score, and stage when discussing your treatment options. What do these mean?

  • Prostate-Specific Antigen (PSA) test. PSA is a protein made by normal cells and prostate cancer cells. PSA is found in the blood and is measured with a blood test. Doctors sometimes watch the rate of change in your PSA levels over time. A score of 4 nanograms (ng) or higher is often the trigger for further tests.

  • Gleason score of your biopsy. When you had a biopsy, tissue samples (called "cores") were taken from several areas in your prostate. The pathologist checked for cancer in the samples using a microscope. He or she can also estimate how much cancer there is by looking at how many tissue samples are positive. A Gleason score (or sum) on a scale of 2 to 10 is assigned to the cancer. This score tells how different the prostate cancer tissue looks from the normal prostate tissue and helps estimate how likely it is that the tumor cells will spread (how aggressive the cancer is).

    A low-risk score is 2 to 4. A low score means that the cancer tissue still looks similar to normal prostate tissue, and the tumor cells are less likely to spread. A score of 5 to 7 means moderate risk, while a score of 8 to 10 means higher risk. As the score gets higher, it means that the prostate cancer tissue becomes more and more different from normal tissue and that the tumor cells are more likely to spread.Most men with early-stage prostate cancer have a Gleason score of 5, 6, or 7.

  • Stage. The stage of cancer is an important factor in choosing a treatment. The stage tells how much the cancer may have grown within the prostate and whether it has spread to other tissues or organs. Doctors use a standard rating system to describe the stage, called the TNM System. T means the size of the main tumor, N means whether nearby lymph nodes are involved, and M means whether the cancer has spread beyond the region around the prostate.

    First, the doctor will assess the stage of your prostate cancer based on clinical findings (such as a physical exam, digital rectal exam, or DRE, and biopsy). If you have surgery to remove your prostate, seminal vesicles or nearby lymph nodes, then your cancer can be assessed from a pathologic stage. This means that by looking at what is removed, doctors are better able to predict your outcome and survival.

    Your doctor may also suggest other tests such as a bone scan, MRI, CT scan, removing lymph nodes in the pelvis, or a seminal vesicle biopsy.

    Prostate cancer tumor stages range from stage T1 to T4. They may also be further classified a, b, or c. This article addresses early stages, which are Stage T1 and T2, where the cancer is confined to the prostate.

Tumor Stages

Sometimes cancer is found "by accident," or incidentally (called T1a or T1b) when men have surgery to correct a non-cancerous prostate enlargement. T1 means that a tumor is not usually felt during a digital rectal exam.

Since most prostate cancer is found through PSA testing, T1c is the stage most often diagnosed through biopsy.

A stage of T2 means that prostate cancer can be felt during a digital rectal exam but that it is still confined to the prostate gland. Your doctor may also assign a, b, or c stages depending on the cancer's size and location in the prostate.

Types of Treatment

Surgery

Surgery is often a treatment choice for men who have earlystage prostate cancer and are in good health. Surgery to remove the prostate is called prostatectomy (PRAHS-ta- TEK-toe-mee). There are two approaches that are typically used by surgeons:

  • Retropubic prostatectomy. Your surgeon can remove the prostate through an incision just above the pubic bone in your lower abdomen. He or she can also check nearby lymph nodes for cancer (see drawing below). This approach gives the surgeon a better chance to spare the nerves (called nerve-sparing surgery) located next to your prostate that control your bladder and erections.


    You may want to talk with your surgeon about techniques that may spare the nerves that control your bladder and erections.

  • Perineal prostatectomy. This type of surgery, which is not used as often, reaches the prostate through an incision between your scrotum and anus.With this method, your surgeon is not able to check the lymph nodes for cancer. It is also more difficult to spare the nerves that control erections. This approach is used when the cancer is confined to the prostate.
Other Options

Cryosurgery freezes and thaws tissue to kill prostate cancer with the surgeon being guided by ultrasound. Also called cryotherapy, it is often used when the prostate has more advanced, yet still confined disease, and when surgery is not an option. The prostate is not removed with this approach.

Cryosurgery can result in injury to the rectum, incontinence, swelling of the scrotum, pain or numbness in the penis, or blocked urine flow. In 1 in 200 cases, a hole (called a fistula) appears between the rectum and prostate. Results depend highly on the doctor's skill and experience. Success rates may not be as high as with prostatectomy or with any form of external beam radiation therapy. Long-term results for this type of treatment are not yet known.

Laparoscopic surgery is the newest type of surgery to remove the prostate. It is done with smaller incisions using a slender tube with a camera on the end (laparoscope), which may be robotically controlled. The scope is inserted through the navel, and the surgeon can see a highly enlarged image of the prostate. Compared with other types of prostatectomy, this technique may lead to shorter hospital stays, faster recovery, and less blood loss and pain. However, it is fairly new and not widely used. Some surgeons have limited experience with this type of surgery. Since it is newer, researchers have not had the chance to follow its effectiveness for as long as they have for standard surgery.

Radiation Therapy

This type of treatment uses high doses of radiation energy to treat cancer. Radiation therapy is an option when cancer is in your prostate but has not spread to other organs. It is also used when you cannot have surgery because of your age, health, or personal choice. There are two types of radiation therapy:

  • External beam radiation. A machine aims radiation at your cancer cells. It rotates around your body, sending radiation from many directions. After the doctor maps out the exact part of your body that needs radiation, treatment usually happens once a day, 5 days a week, for 6 to 8 weeks. Each treatment session usually lasts about 15 minutes. The latest types of radiation are called 3-D Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy (IMRT). These types of radiation are more precise in destroying cancer while leaving nearby healthy cells unharmed. They are designed to lower the exposure of the rectum and bladder to radiation to help lessen side effects.
  • Brachytherapy (BRA-kee-THAYR-uh-pee). This is a type of internal radiation therapy. It is also called seed implants. Radiation is delivered inside your body by implanting tiny seeds in your prostate. Usually 40 to 130 seeds are inserted into the prostate, depending on the size of your prostate. Each seed has a small amount of radioactive material that emits radiation within an inch of its surroundings. Low-dose seeds are left in the prostate permanently, although their radiation lasts for only 3 to 6 months. This procedure is usually done on an outpatient basis, without a hospital stay.

Both types of radiation can be used together (placing radioactive seeds internally and using external beam radiation to kill any cancer that may be close to the prostate) or with hormone therapy.

Watchful Waiting

Watchful waiting is often called "active surveillance" or "observation" and means that you decide to have no active treatment now. Your doctor will want to follow you closely to look for any signs that the disease may be changing. You will have tests like the ones you've already had such as digital rectal exams, PSA tests, and repeat biopsies. You can change your mind and decide to have treatment at any time. Watchful waiting is based on the fact that many early-stage prostate cancers grow so slowly that they may never cause problems or become life threatening. In some cases, it may be a way to avoid the harms of treatment without shortening life expectancy. Or it can be a decision based on your age and other serious health problems - older men in their 70s and 80s may not have the same views about undergoing surgery or radiation therapy as younger men.

About Hormone Therapy
Hormone therapy may be used in combination with other treatment, such as radiation therapy, when the tumor is large. Male sex hormones such as testosterone make prostate tumors grow. Hormone therapy slows a tumor's growth by stopping or blocking testosterone from entering the cancer cells. Hormone therapy can be given for several years. Side effects usually occur during treatment, but they go away after treatment is over. Side effects may include loss of sex drive, impotence, and hot flashes.

Comparing Your Treatment Options

The chart in the next section lists common questions and answers for the three options outlined in this booklet. As mentioned earlier, most men will need more information than this booklet gives to reach their decisions. You may use this chart as a guide for talking with your doctor or researching your options.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov